Scientists have found that one specific cancer antigen—CT-X—is more frequently found in hormone receptor-negative breast cancer than in other types of breast tumors, according to research published online in advance of publication in Proceedings of the National Academy of Sciences.
And this means?
Ultimately, researchers say, vaccines based on CT-X might provide treatment for ER-negative patients.
Whooheee. Keep the research coming. And let's turn it into treatment options.
SOURCE: Anita Grigoriadis, Otavia L. Caballero, Keith S. Hoek, Leonard da Silva, Yao-Tseng Chen, Sandra J. Shin, Achim A. Jungbluth, Lance D. Miller, David Clouston, Jonathan Cebon, Lloyd J. Old, Sunil R. Lakhani, Andrew J. G. Simpson, and A. Munro Neville. "CT-X antigen expression in human breast cancer," Proceedings of the National Academy of Sciences, 2009. www.pnas.org/cgi/doi/10.1073/pnas.0906840106